Business Context and Reporting Period
This Form 8-K filing by Hims & Hers Health, Inc. (HIMS) reports a material executive leadership change. The report date is September 28, 2025, with the effective transition date set for November 2, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure of COO: Nader Kabbani is stepping down as Chief Operating Officer effective November 2, 2025. He will transition to an advisory role providing strategic guidance and support for special global initiatives through July 2026.
- Appointment of New COO: Mike Chi, currently the Chief Commercial Officer, is being elevated to Chief Operating Officer effective November 2, 2025.
- Organizational Restructuring: The Chief Commercial Officer role will be eliminated. Operations, marketing, product, and commercial functions will be consolidated under Mr. Chi.
Management Commentary and Risks
Management highlights Mr. Chi's extensive background, including over 20 years in consumer internet and previous leadership roles at Zola, INTERMIX, and Gilt Groupe. The Compensation Committee plans to review and evaluate potential changes to Mr. Chi's compensation arrangements to reflect his increased responsibilities, subject to final approval. No specific risks or contingencies related to this transition were disclosed in the text.
Investor Verification Checklist
- Confirm the exact date of the leadership transition (November 2, 2025).
- Review the definitive proxy statement filed on April 25, 2025, for Mr. Chi's current compensation details.
- Monitor future filings for the outcome of the Compensation Committee's review regarding Mr. Chi's new compensation package.
- Verify the scope of Nader Kabbani's advisory role and the duration of his engagement through July 2026.